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ABSTRACT 
Objectives: To evaluate the role of MTHFR genetic variants in the etiology of intrauterine fetal death in the second part of 
pregnancy at women from Polish population.
Material and methods: A case-control study was performed on a 76 women with a positive history of at least one in-
trauterine fetal death after 22 gestational week and 400 healthy controls. The MTHFR genotyping for polymorphic sites 
667C > T, 1298A > C, 1793G > A was determined by polymerase chain reaction/restriction fragment length polymorphism 
(PCR/RFLP) method.
Results: For 1298A > C polymorphism, no statistically significant higher frequency of AA vs. AC+CC genotype was observed 
in the IUFD group 67.1 % vs. 55.2% in the control group (OR = 0.61, p = 0.05, pcorr = 0.15). We observed overrepresentation 
of three-locus haplotype CCG (p = 0.20; pcorr = 0.56) and two-locus haplotype CC (p = 0.17; pcorr = 0.48) in the IUFD group 
compared to controls.
Conclusions: There was no observed relationships in genotype frequency of MTHFR 677C > T and 1793G > A variants, 
however 1298A > C showed a slightly higher but statistically insignificant prevalence in IUFD compared to the controls in 
Polish population. Further studies on a larger population are needed.
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INTRODUCTION
Intrauterine fetal death (IUFD) is a very traumatic event 
for the expectant parents. The reason is often unclear, 
which poses the challenge of identifying it. Generally, 
the cause of intrauterine fetal death may be qualified as 
maternal, fetal or placental. Fetal reasons concern mainly 
multiple pregnancy, intrauterine growth restriction, fetal 
defects, genetic disorders and fetal hydrops of various 
etiology. Placental causes include umbilical disorders, 
preterm placental abruption, preterm premature rupture 
of membranes, feto-maternal hemorrhage or placental 
insufficiency. Finally, among some most important ma-
ternal reasons of intrauterine fetal death are post-term 
pregnancy (> 42 gestational week), improperly controlled 
diabetes and other chronic diseases, such as systemic lupus 
erythematosus, antiphospholipid syndrome, infections, 
hypertension, preeclampsia/eclampsia. This group also 
concerns inherited and acquired thrombophilia as well 
as disturbances of folate and choline cycle [1–5]. Unfor-
tunately, the reason of intrauterine fetal death remains 
unknown in 25–60% cases.
Hiperhomocysteinemia in pregnant patients, apart from 
increasing significantly the risk of recurrent miscarriage, may 
also result in development of preeclampsia, fetal hypotro-
phy, preterm placental abruption, preterm delivery, neural 
tube defects, cleft palate and intrauterine fetal death. 
77
Hubert Wolski et al., MTHFR genetic polymorphism and the risk of intrauterine fetal death in Polish women
www. journals.viamedica.pl/ginekologia_polska
5,10-Methylenetetrahydrofolate reductase (MTHFR) is 
a key enzyme in folate metabolism that carries out the ir-
reversible conversion of 5,10-methylenetetrahydrofolate to 
5-methyltetrahydrofolate, thus generating the active form 
of folate required for remethylation of homocysteine to 
methionine. MTHFR gene is highly polymorphic and most of 
the described genetic variants are functional [6–8]. The most 
commonly described nonsynonymous single-nucleotide 
polymorphism (SNP) variants are: alanine-to-valine substitu-
tion at codon 222 (677C > T, rs1801133), glutamate-to-ala-
nine substitution at codon 429 (1298A > C, rs1801131) and 
Arg594Gln (1793G > A, rs2274976).
Aim of the study
The aim of the study was to investigate the associa-
tion between the three MTHFR SNPs and the IUFD in Pol-
ish women, as well as to estimate the effect of haplotypes 
formed by SNPs localized in the same gene.
MATeRIAl AND MeTHODS
The patients were recruited in the Department of Peri-
natology and Women’s Diseases of Poznan University of 
Medical Sciences in years 2009–2015. The Bioethical Com-
mittee of Poznan University of Medical Sciences approved 
the study. Written informed consent was obtained from all 
the participants.
A total of 476 women were enrolled into the case-con-
trol study: 76 patients with at least one intrauterine fetal 
death after 22nd gestational week and 400 healthy controls 
(Tab  1). The inclusion criteria to the study group were 
as follows: Polish citizenship, Caucasian race, positive his-
tory of intrauterine fetal death after 22nd gestational week, 
unknown reason of intrauterine fetal death, no chronic 
diseases at patient. The following data was analyzed: age, 
parity, gestation age at the time of IUFD, obstetrical and 
general medical history, accompanying obstetrical compli-
cations. Women with known reason of IUFD (eg. hyperten-
sion, preeclampsia/eclampsia, placental abruption, infec-
tious diseases, anemia, fetal defects) were excluded from 
the study group. Women with antiphospholipid syndrome, 
anatomical, hormonal, autoimmune, infectious disorders 
at the moment of joining the study group and thrombotic 
events or chronic diseases in medical history, also did not 
qualify for the study.
The control group comprised of healthy women with 
at least two pregnancies ended with a delivery of healthy 
newborn at term and no history of pregnancy complica-
tions, miscarriage, intrauterine fetal death or preeclamp-
sia. All women from the study and control groups were 
taking folic acid 400 μg per day according to worldwide 
recommendations as to folate supplementation during 
pregnancy.  
Genomic DNA was extracted from blood cells using 
QIAamp DNA Blood Mini Kit (Qiagen, Germany). The blood 
samples (about 5 mL) were taken from elbow vein to the 
Monovete tube at the opportunity of standard lab tests. 
Three missense single nucleotide change of the MTHFR gene 
were taken under investigation: 677C > T (rs1801133), 
1298A > C (rs1801131) and 1793G > A (rs2274976). Geno-
typing was performed using a polymerase chain reaction 
and restriction fragment length polymorphism (PCR-RFLP) 
method previously published by Frost et al. (1995), Hanson 
et al. (2001) and Rady et al. (2002), respectively [6, 8, 9]. The 
starters used, restriction enzymes and fragment length after 
hydrolysis are shown in Table 2. 
Statistical analysis
All statistical analyses was performed using R statistical 
system (version 3.5.0, http://cran.r‐project.org). Continuous 
variables are presented as mean ± SD and were analyzed by 
independent ttest. Genotyping success rate yielded 100% 
for all the investigated SNPs. Distributions of genotypes 
were checked with a Hardy-Weinberg equilibrium test.
Two-sided p-values < 0.05 were considered statistically 
significant. Comparison of genotype frequency differences 
between groups was performed by unconditional logistic 
Table 1. Description of studied polymorphisms
SNP Sequence of primers PCR product (bp) Restriction enzyme Products
677C > T (rs1801133) 5’ TGA AGG AGA AGG TGT CTG CGG GA 3’5’ AGG ACG GTG CGG TGA GAG TG 3’ 198
HinfI  
(Eurx)
CC – 198 bp
CT – 198, 175, 23 bp
TT – 175, 23 bp
1298A > C (rs1801131) 5’ CTT CTA CCT GAA GAG CAA GTC-3’5’ CAT GTC CAC AGC ATG GAG-3’ 256
MboII  
(Eurx)
AA – 176, 30, 28, 22 bp
AC – 204, 30, 28, 22 bp
CC – 204, 30, 22 bp
1793G > A
(rs2274976)
5’ CTC TGT GTG TGT GTG CAT GTG TGC G 3’
5’ GGG ACA GGA GTG GCT CCA ACG CAG G 3’ 310
MbiI  
(Thermo Scientific)
GG – 233, 77 bp
GA – 310, 233, 77 bp
AA – 310 bp
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regression using the SNPassoc package [10]. The Bonfer-
roni method was used to adjust for multiple comparisons 
(p = 0.017 for three SNPs). 
Distribution of haplotypes in the study group was com-
pared with chi-squared tests in Haploview software version 
4.2 (https://www.broadinstitute.org/haploview/haploview). 
Permutation tests were used to correct multiple testing 
errors with 1000 simulations.
ReSUlTS
Clinical data analysis
The clinical characteristics of patients enrolled in this 
study were summarized in Table 2. The mean age of case 
and control groups was 30.46 ± 4.35 years, (median 31 years, 
range: 20–42 years) and 30.05 ± 3.51 years, (median 30 years, 
range: 22–44 years), respectively (p = 0.07). No statistical-
ly significant difference was observed in blood pressure, 
height or weight between the two groups. The study group 
had a statistically higher BMI compared to the control group 
(IUFD: 22.58 ± 3.59 vs. 21.57 ± 3.23 kg/m2, p = 0.04). 69 pa-
tients (90.79%) had one IUFD episode while 2 or more such 
episodes occurred in 7 patients (9.21%). The mean gesta-
tional age of IUFD was 30.02 ± 4.95 gestational week. 
Genetic analysis
The genotype and haplotype frequencies of the 
three polymorphisms were in accordance with the Har-
dy-Weinberg equilibrium in both: the case and the control 
groups. The distribution of the genotypes and their ORs for 
association with IUFD risk are shown in Table 3. No signifi-
cant association was found between the presence of MTHFR 
rs1801133 or rs2274976 polymorphism and the incidence 
of IUFD overall. The biggest statistical difference was ob-
served for rs1801131 A > C polymorphism. Best-fit models 
for this SNP were dominant (OR = 0.61, 95% CI = 0.36–1.02; 
p = 0.05; AIC = 418.3) and overdominant (OR = 0.61, 95% 
CI = 0.37–1.00; p = 0.05; AIC = 418.2), also after Bonferroni 
correction pcorr = 0.15. 
We have not found any difference in frequencies for 
investigated MTHFR gene polymorphism between patients 
with one or two and more IUFDs. For 667C > T polymor-
phism in the seven women that had two or more IUFD, five 
had 677CC genotype, one 677CT and one 677TT. In turn, 
their 1298A > C genotype was as follows: two with 1298AA 
(28.6%), four with 1298AC (57.1%) and one woman with 
1298CC (14.3%). All seven women with two or more IUFDs 
had 1793GG genotypes.
Haplotype analysis
The prevalence of MTHFR haplotype frequency in con-
trols and women with intrauterine fetal death is presented in 
Table 4. Haplotype analysis of three (rs1801133, rs1801131, 
rs2274976) and two (rs1801133, rs1801131) MTHFR loci 
revealed respectively four and three haplotypes with a fre-
Table 2. Demographic and clinical characteristics of participants
Parameter IUFD(n = 76)
Control 
(n = 400) p
Age
(years)
mean + SD
median
min–max
30.46 ± 4.35
31
20–42
30.05 ± 3.51
30
22–44
0.07
Systolic pressure  
(mm Hg)
mean + SD
median
min–max
105.80 ± 11.55
102.5
90–140
107.85 ± 9.82
110
80–130
0.11
Diastolic pressure  
(mm Hg)
mean + SD
median
min–max
66.61 ± 10.49
60
55–110
68.16 ± 8.70
70
50–95
0.17
Height
(cm)
mean + SD
median
min–max
165.84 ± 8.58
167.0
150–183
166.43 ± 5.41
166.5
150–180
0.60
Weight
(kg)
mean + SD
median
min–max
62.01 ± 9.91
61
44–99
60.25 ± 9.64
58
45–110
0.15
BMI
(kg/m2)
mean + SD
median
min–max
22.58 ± 3.59
21.67
18.03–38.67
21.74 ± 3.21
20.90
16.53–38.57
0.04
IUFD onetwo or more
69 (90.79%)
7 (9.21%)
0
0 –
Gestational week of IUFD
mean + SD
median
min–max
30.02 ± 4.92
30
22–40
– –
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Table 3. Logistic regression analyses of associations between the MTHFR polymorphism and the risk of IUFD
Genotypes IUFDn (%)
Control
n (%) OR (95% CI) p AIC
677C > T (rs1801133)
CC 42 (55.3) 201 (50.2) 1.00
0.22 421.0CT 24 (31.6) 164 (41.0) 1.43 (0.83–2.46)
TT 10 (13.2) 35 (8.8) 0.73 (0.34–1.59)
Dominant (CC vs. CT + TT) 34 (44.7) 199 (49.8) 1.22 (0.75–2.00) 0.42 421.4
Recessive (CC + CT vs. TT) 66 (86.8) 365(91.2) 0.63 (0.30–1.34) 0.25 420.7
Overdominant (CC + TT vs. CT) 52 (68.4) 236 (59.0) 1.51 (0.89–2.54) 0.12 419.6
log-Additive (0, 1, 2) 76 (16.0) 400 (84.0) 1.01 (0.70–1.47) 0.94 422.0
Minor allele frequency 44 (28.9) 234 (29.2) 1.01 (0.69–1.49) 0.94 840.1
1298A > C (rs1801131)
AA 25 (32.9) 179 (44.8) 1.00
0.12 419.8AC 42 (55.3) 172 (43.0) 0.57 (0.33–0.98)
CC 9 (11.8) 49 (12.2) 0.76 (0.33–1.73)
Dominant (AA vs. AC + CC) 51 (67.1) 221 (55.2) 0.61 (0.36–1.02) 0.05 418.3
Recessive (AA + AC vs. CC) 67 (88.2) 351 (87.8) 1.04 (0.49–2.22) 0.92 422.0
Overdominant (AA + CC vs. AC) 34 (44.7) 228 (57.0) 0.61 (0.37–1.00) 0.05 418.2
log-Additive (0, 1, 2) 76 (16.0) 400 (84.0) 0.78 (0.55–1.12) 0.18 420.2
Minor allele frequency 60 (39.5) 270 (33.8) 1.28 (0.9  1.83) 0.18 838.3
1793G > A (rs2274976)
GG 69 (90.8) 368 (92.0) 1.00 
0.70 423.5GA 7 (9.2) 31 (7.8) 0.83 (0.35–1.96)
AA 0 (0.0) 1 (0.2) 0.00 
Dominant (GG vs. GA + AA) 7 (9.2) 32 (8.0) 0.86 (0.36–2.02) 0.73 421.9
Recessive (GG + GA vs. AA) 76 (100.0) 399 (99.8) 1.00 421.7
Overdominant (GG + AA vs. GA 69 (90.8) 369 (92.2) 0.83 (0.35–1.96) 0.67 421.9
log-Additive (0, 1, 2) 76 (16.0) 400 (84.0) 0.89 (0.39–2.05) 0.70 422.0
Minor allele frequency 7 (4.6) 33 (4.1) 0.89 (0.39–2.05) 0.79 840.0
Table 4. Haplotype analysis of SNPs genotyped in the MTHFR gene
Haplotype Frequency 
(overall)
Frequency
(case,control) χ 
2 p value p value*
rs1801133 rs1801131 rs2274976
C A G 0.361 0.316, 0.370 1.627 0.2022 0.5840
C C G 0.305 0.349, 0.296 1.658 0.1979 0.5640
T A G 0.292 0.289, 0.292 0.006 0.9400 1.0000
C C A 0.042 0.046, 0.041 0.073 0.7867 0.9910
C A 0.361 0.316, 0.370 1.627 0.2022 0.5160
C C 0.347 0.395, 0.338 1.848 0.1741 0.4750
T A 0.292 0.289, 0.292 0.006 0.940 1.0000
*p value calculated using permutation test and a total of 1000 permutations
quency of more than 1%. Higher occurrence of CAG haplo-
type (containing all non-mutated variants) was observed in 
the control group (0.37 vs. 0.32 in IUFD group, pcorr = 0.584). 
The lowest overall p-values, namely p = 0.20 and pcorr = 0.56, 
were observed for a three-locus haplotype CCG and two-lo-
cus — the MTHFR haplotype CC (p = 0.17 and pcorr = 0.48). 
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These haplotypes were observed more frequently in the 
IUFD group than controls (0.35 and 0.40 vs. 0.30 and 0.34 at 
controls).
DISCUSSION
Folate and choline play a pivotal role in many cellu-
lar processes including DNA synthesis, methylation and 
homocysteine metabolism. Folate and choline as well as 
many reactions that depend on their level have been shown 
to be essential for proper intrauterine fetal development. 
Several pregnancy conditions have been indicated to cor-
relate with lower MTHFR activity, with folate and choline 
deficiency and with several MTHFR and PEMT genetic poly-
morphisms [11, 12]. The presence of MTHFR gene polymor-
phism causes mild hypercoagulability while disturbances in 
coagulation cascade during pregnancy may lead to IUFD. 
Thus, IUFD may be a result of specifically unfavorable MTHFR 
gene polymorphism, especially when combined with some 
harmful environmental factors [13–15].
It is worth to underline that as far as we know, our study 
is first in Poland to investigate the association of SNPs and 
intrauterine fetal death in the second part of pregnancy. 
The present study has not revealed any significant role 
of 677C > T or 1793G > A MTHFR gene polymorphism in 
the etiology of intrauterine fetal death. Yet, the most im-
portant observation concerns the role of 1298A > C poly-
morphism, which points to increased risk of obstetrical 
complication in the population of Polish women (genotype 
1298AC: 55.3 vs. 43.0% in the control group, OR = 0.61, 
p = 0.05. Mutated allele 1298C: 39.5 vs. 33.8% in the control 
group, OR = 1.28, p = 0.18).
In the study of Nurk et al. correlation between Leiden 
mutation, MTHFR gene polymorphism and some obstet-
rical complications was analyzed. The research involved 
5874 women from Norwegian population. The presence of 
factor Leiden was correlated with increased rate of preec-
lampsia (OR = 1.63), small gestational weight (OR = 1.34) 
and IUFD (OR = 2.20). Variant allele for the 677C > T MTHFR 
polymorphism was found to strengthen the association 
between FVL and stillbirth (OR 3.34) [16].
Silver et al. analyzed a large population-based case-con-
trol study of stillbirths (488 stillbirths and 1342 live birth 
mothers and 405 stillbirths and 990 live birth fetuses) test-
ing for factor V Leiden, prothrombin 20210G > A, MTHFR 
677C > T and 1298A > C, and plasminogen activating inhibi-
tor (PAI)-1 4G/5G mutations in mother and fetus. Maternal 
factor V Leiden was weakly associated with stillbirth but 
most maternal and fetal thrombophilia, including 677C > T 
and 1298A > C MTHFR polymorphism, were not associated 
with stillbirth [17].
The aim of the study of Murakami et al. was to assess 
the influence of MTHFR genetic variants on the homocyst-
eine serum concentration during early pregnancy. The 
study involved 816 women between 6 and 12 gestational 
week. Homocysteine concentration was significantly higher 
in women with 677TT (p < 0.0001) genotype. Moreover, 
women with hyperhomocysteinemia in the further course 
of pregnancy developed preeclampsia (p < 0.01) and IUFD 
(p < 0.05) more frequently [18].
On the other hand, the study of Hefler et al. revealed no 
correlation between genetic variants resulting in thrombo-
philia (factor V Leiden, H1299R factor V gene, 20210G > A fac-
tor II gene, V34L factor XIII, 677C > T and 1298A>C MTHFR 
gene, 455G > A beta-fibrinogen gene, 4G/5G PAI-1, L33P GPI-
IIa, C282Y HFE, R3500Q apolipoprotein B and E2/E3/E4 apoli-
poproteins) and increased risk of IUFD. A total of 94 women 
with IUFD and 94 healthy women with a positive history of 
at least one normal pregnancy with live birth at term and 
negative history of IUFD were enrolled into the study [19].
There are also some reports indicating the role of co-ex-
istence of 677C > T and 1298A > C MTHFR gene polymor-
phisms in the etiology of obstetrical complications. A pro-
portion of 46% of 113 Turkish women group with obstetrical 
complications were carriers of 677CT and 1298AC MTHFR 
heterozygotic genotypes [20]. There are also some sugges-
tions that the presence of two mutated genotypes 677C > T 
and 1298A > C of MTHFR gene may lead to fetal demise at 
early stages of pregnancy [21, 22].
The most essential is that the analysis of MTHFR genetic 
polymorphism could also identify the risk group of IUFD. In 
light of previous observations that MTHFR polymorphism 
predisposes to very mild thrombophilia, LMWH prophylaxis 
could be considered for women in IUFD risk group. Such 
recommendation would be in line with the findings of Aracic 
et al. who showed that LMWH prophylaxis has reduced the 
incidence of fetal growth restriction (FGR), preterm birth 
(PTB) and IUFD in women carrying the MTHFR, ACE and 
PAI-1 genetic variants [23]. 
CONClUSIONS
In conclusion, our results showed no significant relation-
ship between MTHFR 677C > T and 1793G > A genotypes 
distribution among patients with IUFD and controls. The 
1298A > C variant showed a slightly higher but statistically 
insignificant prevalence of IUFD compared to the controls 
in Polish population. 
On the basis of obtained results it might be suggested 
that there is no influence of investigated polymorphisms 
on the risk of intrauterine fetal death in Polish population. 
But of course,  further studies on a larger population are 
needed. To better understand the pathobiology of IUFD, 
we need to know more about interactions of polymorphic 
variants with each other and with the environment. It is 
also worth to underline that probable role of MTHFR gene 
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polymorphisms in the etiology of intrauterine fetal death 
may be a result of hyperhomocysteinemia caused by these 
genetic variants [24–26].
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